The Molekulare Krebsforschungszentrum of the Charité –MKFZ, has its research focus in translational (bench to bed-side) research of molecular processes in the initiation and development of diverse cancer types. Molecular findings of current research projects of MKFZ groups will potentially lead to completely novel therapy strategies which up to now are not being considered for cancer therapies. Therefore, you will find current routine medication and specific cancer therapy on the webpages of the participating clinics and departments and the Charité Comprehensive Cancer Center.

On the following pages you will find all topics and further information of the participating MKFZ research groups.